Abstract submission

Submit abstract


One single abstract per presenting author can be submitted; however, submitters can be co-authors on several abstract.

Style and instructions*

File format

Word (.doc, .docx)




Times New Roman, 11-point font


Boldface, lowercase letters  

Authors Names

For each author, type in: last name, first name and indexes of the affiliations separated by a comma. (Eg: Rossi Mario 1,2,3)

List of author institutions:


Abstract body

Less than 300 words, single space

Please note: it is mandatory including, after the abstract body:

  • Name of the presenting author
  • E-mail and phone number of the presenting author
  • Current status of the presenting author (undergraduate/graduate student,PhD student, Postdoctoral fellow, Assistant/Associate/Full professor, Nonacademic researcher, other)**

* Abstracts which do not follow instructions will be rejected
**Abstracts which do not contain that information will be rejected  

Final selection

Abstracts will be evaluated by a Scientific Committee and notification on their acceptance will be sent to the presenting author tentatively by July 5th, 2024.  

Abstracts will be considered in one of the following areas:

  • CNS primary tumours
  • Brain metastasis
  • Brain cancer/metastasis remodelling of brain circuits and functions
  • Cancer-neuron synapses
  • Neural stem cells and cancer
  • Glial cells in cancer
  • Neurogenesis and axonogenesis in cancer
  • Neuronal transdifferentiation of cancer cells
  • Neuroimmune axis in cancer and cancer microenvironment
  • BBB and cancer
  • Meninges and cancer
  • Perineural invasion in peripheral tumours
  • Cancer and pain
  • Cancer-associated cachexia
  • Cancer-induced epilepsy
  • Sleep disruption and cancer
  • Circadian rhythms and cancer
  • Metabolic and immunologic disruptions in cancer
  • Cognitive effects of cancer and cancer treatments
  • Cancer/cancer therapy and mood disorders
  • CART cell therapy in primary brain tumors
  • Neuronal /neural mechanisms in chemoresistance of cancer cells
  • Drug repurposing based on brain/neurons-tumour interactions
  • Neurodevelopment disorders and cancer susceptibility
  • Neuromuscular disorders and cancer
  • Neurodegenerative disorders and cancer